Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)

TYO:2395 Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 15, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	56,619	59,575	63,197	114,488	70,608	29,101
Market Cap Growth	-5.73%	-5.73%	-44.80%	62.15%	142.63%	32.39%
Enterprise Value	79,122	83,708	76,952	122,471	74,176	36,794
Last Close Price	1360.00	1431.00	1463.63	2572.85	1557.71	626.92
PE Ratio	11.50	12.10	11.43	18.89	9.91	7.95
Forward PE	12.38	-	-	-	-	-
PS Ratio	1.75	1.84	2.39	4.56	3.98	1.93
PB Ratio	1.41	1.49	1.85	4.34	3.58	1.84
P/TBV Ratio	1.49	1.57	1.98	4.67	3.65	1.88
P/FCF Ratio	-	-	-	-	16.01	7.91
P/OCF Ratio	8.05	8.47	30.01	28.59	11.86	6.13
EV/Sales Ratio	2.44	2.58	2.91	4.88	4.18	2.44
EV/EBITDA Ratio	8.69	14.96	12.76	17.89	13.81	9.90
EV/EBIT Ratio	12.18	28.04	18.49	23.35	17.68	14.55
EV/FCF Ratio	-20.72	-	-	-	16.82	10.00
Debt / Equity Ratio	0.86	0.86	0.77	0.71	0.46	0.80
Debt / EBITDA Ratio	6.16	6.16	4.34	2.74	1.70	3.41
Debt / FCF Ratio	-	-	-	-	2.07	3.45
Asset Turnover	0.38	0.38	0.40	0.52	0.47	0.40
Inventory Turnover	1.24	1.24	1.24	2.06	1.91	1.87
Quick Ratio	0.63	0.63	0.69	0.73	0.79	0.86
Current Ratio	1.13	1.13	1.31	1.14	1.21	1.24
Return on Equity (ROE)	13.10%	13.10%	18.24%	26.26%	40.30%	22.82%
Return on Assets (ROA)	2.21%	2.21%	3.90%	6.79%	6.88%	4.16%
Return on Capital (ROIC)	2.77%	2.77%	4.93%	8.86%	9.14%	5.28%
Return on Capital Employed (ROCE)	4.70%	4.70%	7.90%	14.50%	16.20%	10.10%
Earnings Yield	8.70%	8.27%	8.75%	5.29%	10.09%	12.58%
FCF Yield	-6.74%	-6.41%	-10.25%	-0.73%	6.25%	12.64%
Dividend Yield	3.66%	-	3.42%	1.94%	1.93%	1.59%
Payout Ratio	42.65%	42.65%	37.48%	41.01%	11.60%	5.65%
Buyback Yield / Dilution	-	-	-	0.00%	-	-
Total Shareholder Return	3.58%	-	3.42%	1.94%	1.93%	1.59%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.